Jason Gien
Concepts (327)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hernias, Diaphragmatic, Congenital | 36 | 2024 | 204 | 9.790 |
Why?
| Extracorporeal Membrane Oxygenation | 17 | 2024 | 286 | 3.490 |
Why?
| Acute Kidney Injury | 12 | 2023 | 791 | 2.200 |
Why?
| Hypertension, Pulmonary | 16 | 2022 | 1894 | 1.980 |
Why?
| Bronchopulmonary Dysplasia | 10 | 2023 | 379 | 1.810 |
Why?
| Persistent Fetal Circulation Syndrome | 7 | 2016 | 137 | 1.620 |
Why?
| rho-Associated Kinases | 5 | 2016 | 87 | 1.600 |
Why?
| Infant, Newborn | 47 | 2024 | 5756 | 1.510 |
Why?
| Neovascularization, Physiologic | 6 | 2013 | 175 | 1.390 |
Why?
| Pulmonary Artery | 14 | 2018 | 1097 | 1.370 |
Why?
| Endothelin-1 | 4 | 2016 | 179 | 1.310 |
Why?
| Endothelial Cells | 10 | 2018 | 749 | 1.300 |
Why?
| Nitric Oxide | 8 | 2020 | 895 | 1.200 |
Why?
| Tracheostomy | 5 | 2016 | 127 | 1.020 |
Why?
| Lung | 16 | 2024 | 3938 | 1.010 |
Why?
| Enterocolitis, Necrotizing | 2 | 2023 | 36 | 0.890 |
Why?
| Ostomy | 1 | 2023 | 3 | 0.880 |
Why?
| Respiration, Artificial | 4 | 2016 | 613 | 0.870 |
Why?
| Infant | 24 | 2023 | 8995 | 0.830 |
Why?
| PPAR gamma | 2 | 2013 | 183 | 0.790 |
Why?
| Infant, Newborn, Diseases | 1 | 2023 | 110 | 0.770 |
Why?
| Sheep | 14 | 2018 | 845 | 0.770 |
Why?
| Patient Care Team | 3 | 2016 | 600 | 0.730 |
Why?
| Retrospective Studies | 35 | 2024 | 14522 | 0.720 |
Why?
| Ductus Arteriosus, Patent | 3 | 2023 | 49 | 0.710 |
Why?
| Prenatal Diagnosis | 3 | 2024 | 194 | 0.710 |
Why?
| Water-Electrolyte Imbalance | 4 | 2022 | 42 | 0.710 |
Why?
| Length of Stay | 7 | 2019 | 1122 | 0.700 |
Why?
| Reperfusion Injury | 1 | 2023 | 272 | 0.690 |
Why?
| Blood Gas Analysis | 2 | 2021 | 71 | 0.680 |
Why?
| Vasodilator Agents | 4 | 2016 | 326 | 0.650 |
Why?
| Transportation of Patients | 1 | 2020 | 50 | 0.640 |
Why?
| Vascular Endothelial Growth Factor A | 6 | 2023 | 530 | 0.630 |
Why?
| Respiratory Insufficiency | 2 | 2020 | 313 | 0.610 |
Why?
| Bronchodilator Agents | 1 | 2020 | 241 | 0.590 |
Why?
| Pregnancy | 20 | 2024 | 6417 | 0.580 |
Why?
| Shock, Septic | 1 | 2020 | 209 | 0.570 |
Why?
| Continuity of Patient Care | 2 | 2016 | 273 | 0.540 |
Why?
| Humans | 62 | 2024 | 129627 | 0.510 |
Why?
| Trachea | 1 | 2018 | 226 | 0.510 |
Why?
| Ventilator Weaning | 1 | 2016 | 36 | 0.500 |
Why?
| Myocytes, Smooth Muscle | 2 | 2015 | 259 | 0.480 |
Why?
| Hemodynamics | 4 | 2022 | 1090 | 0.480 |
Why?
| Umbilical Arteries | 1 | 2015 | 53 | 0.480 |
Why?
| Radial Artery | 1 | 2015 | 69 | 0.480 |
Why?
| Vasoconstrictor Agents | 2 | 2018 | 127 | 0.460 |
Why?
| Herniorrhaphy | 3 | 2020 | 57 | 0.460 |
Why?
| Infant, Premature | 10 | 2023 | 542 | 0.460 |
Why?
| Sepsis | 2 | 2020 | 575 | 0.460 |
Why?
| Female | 43 | 2024 | 68735 | 0.440 |
Why?
| Infant, Extremely Premature | 1 | 2014 | 61 | 0.430 |
Why?
| Vasopressins | 1 | 2014 | 64 | 0.430 |
Why?
| Central Nervous System Diseases | 1 | 2014 | 69 | 0.430 |
Why?
| Weight Gain | 1 | 2017 | 509 | 0.410 |
Why?
| Patient Discharge | 4 | 2021 | 836 | 0.410 |
Why?
| Hypotension | 1 | 2014 | 116 | 0.410 |
Why?
| Hernia, Diaphragmatic | 3 | 2021 | 69 | 0.400 |
Why?
| Hospital Mortality | 3 | 2021 | 848 | 0.390 |
Why?
| Oxygen Consumption | 1 | 2015 | 672 | 0.390 |
Why?
| Echocardiography | 5 | 2023 | 634 | 0.390 |
Why?
| Gastrostomy | 3 | 2023 | 110 | 0.390 |
Why?
| Practice Guidelines as Topic | 1 | 2020 | 1501 | 0.380 |
Why?
| Developmental Disabilities | 1 | 2014 | 261 | 0.370 |
Why?
| Enzyme Activation | 1 | 2012 | 813 | 0.350 |
Why?
| Communication | 1 | 2016 | 838 | 0.340 |
Why?
| Animals, Newborn | 5 | 2023 | 835 | 0.340 |
Why?
| Magnetic Resonance Imaging | 4 | 2023 | 3394 | 0.320 |
Why?
| Pulmonary Alveoli | 4 | 2014 | 403 | 0.310 |
Why?
| Endothelium, Vascular | 3 | 2013 | 903 | 0.300 |
Why?
| Cardiopulmonary Resuscitation | 2 | 2022 | 233 | 0.300 |
Why?
| Kidney | 6 | 2023 | 1386 | 0.300 |
Why?
| Bacteremia | 3 | 2019 | 194 | 0.290 |
Why?
| Lung Volume Measurements | 3 | 2023 | 45 | 0.280 |
Why?
| Survival Rate | 4 | 2022 | 1872 | 0.270 |
Why?
| Sulfonamides | 3 | 2016 | 497 | 0.270 |
Why?
| Animals | 18 | 2023 | 35391 | 0.270 |
Why?
| Fetal Growth Retardation | 3 | 2018 | 550 | 0.260 |
Why?
| Ventricular Dysfunction, Left | 2 | 2022 | 385 | 0.260 |
Why?
| Fetal Diseases | 1 | 2007 | 158 | 0.250 |
Why?
| Male | 26 | 2024 | 63671 | 0.250 |
Why?
| Morbidity | 2 | 2023 | 302 | 0.250 |
Why?
| Risk Factors | 9 | 2021 | 9786 | 0.240 |
Why?
| Receptors, Endothelin | 2 | 2016 | 50 | 0.240 |
Why?
| Cells, Cultured | 8 | 2014 | 4084 | 0.240 |
Why?
| Urinary Tract Infections | 4 | 2019 | 151 | 0.230 |
Why?
| Fetus | 6 | 2023 | 774 | 0.230 |
Why?
| Hirudins | 1 | 2024 | 53 | 0.230 |
Why?
| Antithrombins | 1 | 2024 | 58 | 0.220 |
Why?
| Signal Transduction | 6 | 2018 | 4931 | 0.220 |
Why?
| Renal Replacement Therapy | 2 | 2022 | 87 | 0.220 |
Why?
| Postoperative Hemorrhage | 1 | 2024 | 87 | 0.220 |
Why?
| Endotoxins | 2 | 2015 | 220 | 0.210 |
Why?
| Hernia, Umbilical | 1 | 2023 | 16 | 0.210 |
Why?
| Treatment Outcome | 7 | 2022 | 10219 | 0.210 |
Why?
| Pulmonary Veins | 2 | 2014 | 98 | 0.210 |
Why?
| Nitric Oxide Synthase Type III | 4 | 2013 | 203 | 0.210 |
Why?
| Severity of Illness Index | 5 | 2020 | 2739 | 0.210 |
Why?
| Heparin | 1 | 2024 | 254 | 0.200 |
Why?
| Fundoplication | 2 | 2020 | 54 | 0.200 |
Why?
| Umbilical Cord | 1 | 2023 | 83 | 0.200 |
Why?
| Pulmonary Circulation | 4 | 2014 | 431 | 0.200 |
Why?
| Parturition | 1 | 2023 | 71 | 0.200 |
Why?
| Tracheobronchomalacia | 1 | 2022 | 14 | 0.200 |
Why?
| Fetal Blood | 1 | 2024 | 317 | 0.190 |
Why?
| Tracheomalacia | 1 | 2022 | 15 | 0.190 |
Why?
| Biomarkers | 3 | 2024 | 3968 | 0.190 |
Why?
| Surgical Flaps | 2 | 2023 | 136 | 0.190 |
Why?
| Gestational Age | 7 | 2021 | 876 | 0.190 |
Why?
| Tracheoesophageal Fistula | 1 | 2022 | 33 | 0.190 |
Why?
| Neuromuscular Blockade | 1 | 2021 | 22 | 0.180 |
Why?
| Peptide Fragments | 1 | 2024 | 693 | 0.170 |
Why?
| Guanylate Cyclase | 2 | 2011 | 35 | 0.170 |
Why?
| Benzoates | 2 | 2011 | 41 | 0.170 |
Why?
| Interactive Ventilatory Support | 1 | 2020 | 2 | 0.170 |
Why?
| Anti-Bacterial Agents | 3 | 2019 | 1705 | 0.170 |
Why?
| Analgesia | 1 | 2021 | 100 | 0.170 |
Why?
| Serotonin | 2 | 2013 | 318 | 0.170 |
Why?
| Anticoagulants | 1 | 2024 | 637 | 0.170 |
Why?
| Prospective Studies | 5 | 2024 | 7135 | 0.160 |
Why?
| Therapy, Computer-Assisted | 1 | 2020 | 60 | 0.160 |
Why?
| Infant Mortality | 2 | 2019 | 106 | 0.160 |
Why?
| Adrenal Cortex Hormones | 2 | 2015 | 524 | 0.160 |
Why?
| Thrombelastography | 1 | 2020 | 150 | 0.160 |
Why?
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 2 | 2016 | 28 | 0.160 |
Why?
| Heart Failure | 2 | 2022 | 2133 | 0.160 |
Why?
| Heart Atria | 1 | 2020 | 129 | 0.160 |
Why?
| Rats | 4 | 2023 | 5483 | 0.150 |
Why?
| Diuretics | 2 | 2018 | 77 | 0.150 |
Why?
| Asphyxia Neonatorum | 1 | 2018 | 18 | 0.150 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2011 | 217 | 0.150 |
Why?
| Blood Coagulation Disorders | 1 | 2020 | 167 | 0.150 |
Why?
| NF-kappa B p50 Subunit | 1 | 2018 | 24 | 0.150 |
Why?
| Disease Models, Animal | 5 | 2015 | 4078 | 0.150 |
Why?
| Child | 8 | 2022 | 20884 | 0.150 |
Why?
| Cell Proliferation | 3 | 2015 | 2373 | 0.140 |
Why?
| MicroRNAs | 1 | 2024 | 679 | 0.140 |
Why?
| Transcription Factor RelA | 1 | 2018 | 84 | 0.140 |
Why?
| Monitoring, Physiologic | 1 | 2019 | 265 | 0.140 |
Why?
| Intensive Care Units, Neonatal | 5 | 2018 | 226 | 0.140 |
Why?
| Survival Analysis | 2 | 2020 | 1269 | 0.140 |
Why?
| Administration, Inhalation | 2 | 2016 | 667 | 0.140 |
Why?
| Blood Vessels | 2 | 2016 | 187 | 0.140 |
Why?
| Brain Diseases | 1 | 2018 | 136 | 0.140 |
Why?
| Injections, Intraperitoneal | 1 | 2016 | 112 | 0.130 |
Why?
| Infant Care | 1 | 2016 | 45 | 0.130 |
Why?
| Expectorants | 1 | 2016 | 24 | 0.130 |
Why?
| Rats, Sprague-Dawley | 3 | 2016 | 2395 | 0.130 |
Why?
| Interrupted Time Series Analysis | 1 | 2016 | 54 | 0.130 |
Why?
| Bacterial Infections | 1 | 2018 | 235 | 0.130 |
Why?
| Ventilators, Mechanical | 1 | 2016 | 56 | 0.130 |
Why?
| Cross Infection | 1 | 2018 | 217 | 0.130 |
Why?
| Hypertrophy, Right Ventricular | 1 | 2016 | 145 | 0.130 |
Why?
| Dimensional Measurement Accuracy | 1 | 2015 | 13 | 0.130 |
Why?
| Fluorescent Antibody Technique | 1 | 2016 | 376 | 0.120 |
Why?
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2015 | 17 | 0.120 |
Why?
| Intubation, Intratracheal | 1 | 2018 | 242 | 0.120 |
Why?
| Steroids | 1 | 2016 | 158 | 0.120 |
Why?
| Preoperative Care | 1 | 2017 | 338 | 0.120 |
Why?
| Receptors, Calcitriol | 1 | 2015 | 53 | 0.120 |
Why?
| Databases, Factual | 5 | 2018 | 1269 | 0.120 |
Why?
| High-Frequency Ventilation | 1 | 2015 | 45 | 0.120 |
Why?
| Predictive Value of Tests | 1 | 2020 | 1947 | 0.120 |
Why?
| Bleomycin | 1 | 2016 | 243 | 0.120 |
Why?
| Case-Control Studies | 2 | 2024 | 3378 | 0.120 |
Why?
| Peptides, Cyclic | 1 | 2016 | 256 | 0.120 |
Why?
| Clinical Decision-Making | 1 | 2017 | 301 | 0.120 |
Why?
| Piperidines | 1 | 2016 | 201 | 0.120 |
Why?
| Oligopeptides | 1 | 2016 | 258 | 0.120 |
Why?
| Catalase | 1 | 2015 | 128 | 0.120 |
Why?
| Statistics as Topic | 1 | 2015 | 305 | 0.110 |
Why?
| Positive-Pressure Respiration | 1 | 2015 | 76 | 0.110 |
Why?
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 55 | 0.110 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 86 | 0.110 |
Why?
| Arteriovenous Fistula | 1 | 2014 | 35 | 0.110 |
Why?
| Adrenergic beta-Agonists | 1 | 2015 | 133 | 0.110 |
Why?
| Coculture Techniques | 1 | 2015 | 223 | 0.110 |
Why?
| Cyclic GMP | 2 | 2011 | 90 | 0.110 |
Why?
| Capillaries | 1 | 2014 | 103 | 0.110 |
Why?
| Endothelin Receptor Antagonists | 1 | 2013 | 62 | 0.110 |
Why?
| Logistic Models | 4 | 2020 | 1986 | 0.110 |
Why?
| Pregnancy Trimester, Third | 2 | 2024 | 109 | 0.100 |
Why?
| Receptor, Serotonin, 5-HT2A | 1 | 2013 | 20 | 0.100 |
Why?
| Ligation | 1 | 2012 | 87 | 0.100 |
Why?
| Ductus Arteriosus | 1 | 2012 | 72 | 0.100 |
Why?
| Vitamins | 1 | 2014 | 173 | 0.100 |
Why?
| Superoxide Dismutase | 1 | 2015 | 342 | 0.100 |
Why?
| RNA, Small Interfering | 1 | 2015 | 591 | 0.100 |
Why?
| Diaphragm | 2 | 2023 | 42 | 0.100 |
Why?
| Hospitalization | 2 | 2021 | 2057 | 0.100 |
Why?
| Immunohistochemistry | 1 | 2016 | 1685 | 0.100 |
Why?
| Amides | 1 | 2012 | 91 | 0.100 |
Why?
| Pyridines | 2 | 2012 | 478 | 0.100 |
Why?
| Reactive Oxygen Species | 1 | 2015 | 593 | 0.090 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 329 | 0.090 |
Why?
| DNA Primers | 1 | 2012 | 511 | 0.090 |
Why?
| RNA Interference | 1 | 2012 | 450 | 0.090 |
Why?
| In Vitro Techniques | 1 | 2012 | 1087 | 0.090 |
Why?
| Isoenzymes | 1 | 2011 | 301 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 824 | 0.090 |
Why?
| Protein Binding | 1 | 2016 | 2124 | 0.090 |
Why?
| Vitamin D | 1 | 2014 | 381 | 0.080 |
Why?
| Transforming Growth Factor beta1 | 1 | 2011 | 158 | 0.080 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 834 | 0.080 |
Why?
| Ultrasonography, Prenatal | 2 | 2022 | 274 | 0.080 |
Why?
| Blotting, Western | 1 | 2012 | 1206 | 0.080 |
Why?
| Prognosis | 3 | 2023 | 3774 | 0.080 |
Why?
| Amniotic Fluid | 2 | 2024 | 87 | 0.080 |
Why?
| Analysis of Variance | 1 | 2012 | 1293 | 0.080 |
Why?
| Vasodilation | 2 | 2011 | 476 | 0.080 |
Why?
| Hypoxia | 1 | 2016 | 1084 | 0.080 |
Why?
| Myosin-Light-Chain Phosphatase | 1 | 2008 | 3 | 0.080 |
Why?
| Dipeptides | 1 | 2008 | 47 | 0.070 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2023 | 338 | 0.070 |
Why?
| Nitroarginine | 1 | 2007 | 57 | 0.070 |
Why?
| Quality Improvement | 1 | 2016 | 1101 | 0.070 |
Why?
| Phosphorylation | 2 | 2011 | 1713 | 0.070 |
Why?
| Incidence | 3 | 2019 | 2641 | 0.070 |
Why?
| Enzyme Inhibitors | 2 | 2009 | 827 | 0.070 |
Why?
| Pilot Projects | 2 | 2024 | 1592 | 0.070 |
Why?
| Postoperative Complications | 2 | 2017 | 2477 | 0.070 |
Why?
| Blood Pressure | 1 | 2014 | 1736 | 0.070 |
Why?
| Oxadiazoles | 3 | 2011 | 33 | 0.070 |
Why?
| Nitric Oxide Synthase | 1 | 2007 | 237 | 0.070 |
Why?
| Vascular Resistance | 3 | 2013 | 371 | 0.060 |
Why?
| Pulmonary Edema | 1 | 2006 | 106 | 0.060 |
Why?
| Cell Division | 1 | 2007 | 796 | 0.060 |
Why?
| Child, Preschool | 2 | 2020 | 10490 | 0.060 |
Why?
| Hyperoxia | 1 | 2006 | 90 | 0.060 |
Why?
| Hospitals, Pediatric | 2 | 2020 | 513 | 0.060 |
Why?
| Recombinant Proteins | 2 | 2024 | 1308 | 0.060 |
Why?
| Odds Ratio | 2 | 2018 | 1019 | 0.060 |
Why?
| Cell Membrane | 1 | 2008 | 734 | 0.060 |
Why?
| Phenotype | 2 | 2016 | 3075 | 0.060 |
Why?
| Fetal Development | 1 | 2007 | 288 | 0.060 |
Why?
| Adult | 4 | 2024 | 35600 | 0.050 |
Why?
| Liver | 2 | 2022 | 1842 | 0.050 |
Why?
| Indomethacin | 1 | 2023 | 78 | 0.050 |
Why?
| Ketanserin | 2 | 2013 | 12 | 0.050 |
Why?
| Serotonin 5-HT2 Receptor Antagonists | 2 | 2013 | 10 | 0.050 |
Why?
| Sertraline | 2 | 2013 | 30 | 0.050 |
Why?
| Chronic Disease | 1 | 2008 | 1720 | 0.050 |
Why?
| Water-Electrolyte Balance | 1 | 2022 | 34 | 0.050 |
Why?
| Creatinine | 1 | 2023 | 490 | 0.040 |
Why?
| Soluble Guanylyl Cyclase | 2 | 2011 | 15 | 0.040 |
Why?
| Benzodiazepines | 1 | 2021 | 134 | 0.040 |
Why?
| Quinoxalines | 2 | 2011 | 64 | 0.040 |
Why?
| Proteus | 1 | 2019 | 6 | 0.040 |
Why?
| Risk Assessment | 2 | 2020 | 3262 | 0.040 |
Why?
| Enterobacter | 1 | 2019 | 7 | 0.040 |
Why?
| Young Adult | 1 | 2016 | 12455 | 0.040 |
Why?
| Hypnotics and Sedatives | 1 | 2021 | 175 | 0.040 |
Why?
| Cardiac Catheterization | 1 | 2022 | 520 | 0.040 |
Why?
| Intubation | 1 | 2018 | 3 | 0.040 |
Why?
| Aftercare | 1 | 2021 | 203 | 0.040 |
Why?
| Tertiary Care Centers | 1 | 2020 | 148 | 0.040 |
Why?
| Oligohydramnios | 1 | 2018 | 11 | 0.040 |
Why?
| Polyhydramnios | 1 | 2018 | 17 | 0.040 |
Why?
| Apgar Score | 1 | 2018 | 16 | 0.040 |
Why?
| Protective Factors | 1 | 2019 | 91 | 0.040 |
Why?
| Intensive Care, Neonatal | 1 | 2018 | 40 | 0.040 |
Why?
| Heart | 1 | 2022 | 641 | 0.040 |
Why?
| Surgical Mesh | 1 | 2018 | 46 | 0.040 |
Why?
| Datasets as Topic | 1 | 2018 | 109 | 0.040 |
Why?
| Time Factors | 2 | 2020 | 6555 | 0.040 |
Why?
| Intensive Care Units, Pediatric | 1 | 2020 | 203 | 0.040 |
Why?
| Congenital Abnormalities | 1 | 2018 | 76 | 0.040 |
Why?
| Infant, Low Birth Weight | 1 | 2018 | 135 | 0.040 |
Why?
| Drug Utilization | 1 | 2018 | 171 | 0.040 |
Why?
| Pneumonia | 2 | 2018 | 617 | 0.040 |
Why?
| Gene Expression | 2 | 2013 | 1465 | 0.030 |
Why?
| Hydrogen-Ion Concentration | 1 | 2018 | 541 | 0.030 |
Why?
| Age of Onset | 1 | 2018 | 495 | 0.030 |
Why?
| Catheterization, Central Venous | 1 | 2018 | 104 | 0.030 |
Why?
| Arterial Pressure | 1 | 2017 | 118 | 0.030 |
Why?
| Adolescent | 1 | 2016 | 20412 | 0.030 |
Why?
| Blood Pressure Determination | 1 | 2017 | 148 | 0.030 |
Why?
| Ventricular Function, Left | 1 | 2020 | 528 | 0.030 |
Why?
| Clinical Protocols | 1 | 2017 | 254 | 0.030 |
Why?
| Recurrence | 1 | 2019 | 1011 | 0.030 |
Why?
| Antimicrobial Stewardship | 1 | 2018 | 107 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 2 | 2011 | 2011 | 0.030 |
Why?
| Postpartum Period | 1 | 2019 | 333 | 0.030 |
Why?
| Vitamin D3 24-Hydroxylase | 1 | 2015 | 15 | 0.030 |
Why?
| Calcifediol | 1 | 2015 | 31 | 0.030 |
Why?
| Risk Adjustment | 1 | 2016 | 79 | 0.030 |
Why?
| United States | 3 | 2018 | 13871 | 0.030 |
Why?
| Birth Weight | 1 | 2018 | 506 | 0.030 |
Why?
| Escherichia coli | 1 | 2019 | 767 | 0.030 |
Why?
| Staphylococcus aureus | 1 | 2019 | 434 | 0.030 |
Why?
| Heart Ventricles | 1 | 2020 | 781 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2018 | 877 | 0.030 |
Why?
| Primary Prevention | 1 | 2016 | 190 | 0.030 |
Why?
| Oxygen Inhalation Therapy | 1 | 2015 | 143 | 0.030 |
Why?
| Analgesics, Opioid | 1 | 2021 | 913 | 0.030 |
Why?
| Sheep, Domestic | 1 | 2013 | 34 | 0.030 |
Why?
| Tryptophan Hydroxylase | 1 | 2013 | 53 | 0.030 |
Why?
| Age Factors | 1 | 2020 | 3152 | 0.020 |
Why?
| Precision Medicine | 1 | 2016 | 387 | 0.020 |
Why?
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 199 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2016 | 1499 | 0.020 |
Why?
| Hysterotomy | 1 | 2011 | 9 | 0.020 |
Why?
| Cell Aggregation | 1 | 2011 | 23 | 0.020 |
Why?
| Receptors, Serotonin | 1 | 2011 | 33 | 0.020 |
Why?
| Nitroprusside | 1 | 2011 | 67 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2011 | 84 | 0.020 |
Why?
| Receptor, Insulin | 1 | 2011 | 99 | 0.020 |
Why?
| Heart Defects, Congenital | 1 | 2018 | 792 | 0.020 |
Why?
| Cohort Studies | 1 | 2021 | 5426 | 0.020 |
Why?
| Fluoxetine | 1 | 2011 | 52 | 0.020 |
Why?
| Disease Management | 1 | 2015 | 588 | 0.020 |
Why?
| Primary Cell Culture | 1 | 2011 | 164 | 0.020 |
Why?
| Registries | 1 | 2018 | 1899 | 0.020 |
Why?
| Cell Hypoxia | 1 | 2011 | 234 | 0.020 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2016 | 1365 | 0.020 |
Why?
| Hydrogen Peroxide | 1 | 2011 | 317 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 432 | 0.020 |
Why?
| Pulmonary Wedge Pressure | 1 | 2009 | 66 | 0.020 |
Why?
| Piperazines | 1 | 2011 | 340 | 0.020 |
Why?
| Oxygen | 1 | 2014 | 915 | 0.020 |
Why?
| Acetylcholine | 1 | 2009 | 183 | 0.020 |
Why?
| Indoles | 1 | 2011 | 383 | 0.020 |
Why?
| Prevalence | 1 | 2015 | 2564 | 0.020 |
Why?
| Cell Movement | 1 | 2011 | 948 | 0.020 |
Why?
| Muscle, Smooth, Vascular | 1 | 2009 | 444 | 0.020 |
Why?
| Organ Size | 1 | 2006 | 446 | 0.020 |
Why?
| Body Weight | 1 | 2006 | 940 | 0.010 |
Why?
| Insulin | 1 | 2011 | 2326 | 0.010 |
Why?
|
|
Gien's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|